Safety of Arthritis Drugs, Day 3. Part 4
This is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees. At the end of the three-day forum the 32-member panel had recommended …
140 viewsThis is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees. At the end of the three-day forum the 32-member panel had recommended …
140 viewsAt a joint meeting of the Arthritis and Drug Safety and Risk Management Advisory Committees, experts discussed the safety of arthritis drugs called “COX-2” inhibitors. Dr. Anne Trontell gave…
236 viewsPhysicians spoke at a meeting to assess the safety records of arthritis drugs. Representatives for the drug Arcoxia and for the Food and Drug Administration spoke about a number of issues in…
218 views